Cardiology
News
The thyroid takes a beating during PCI in about 3% of patients
Some patients may have temporarily impaired thyroid function after undergoing percutaneous coronary intervention.
Conference Coverage
Empiric warfarin adjustment cut drug-drug interactions with antimicrobials
Key clinical point: Clinical guidelines with empiric warfarin adjustments improved time within therapeutic range (TWTR) for inpatients on...
Conference Coverage
CardioMEMS shows real-world heart failure benefit
Key clinical point: Registry data from the first 2,000 U.S.
Conference Coverage
CABG reduces cardiovascular mortality in ischemic heart failure regardless of age
ROME – There should be no age cutoff in offering CABG to older patients with ischemic heart failure.
Conference Coverage
ESC’s new lipid guidelines keep LDL-cholesterol targets
Conference Coverage
Optimal medical therapy doesn’t affect DAPT efficacy
ROME – The decision to use DAPT beyond 12 months should be made irrespective of OMT use.
Conference Coverage
Decision rule identifies unprovoked VTE patients who can halt anticoagulation
ROME – Half of women who have a first unprovoked venous thromboembolism can safely be spared lifelong anticoagulation through application of the...
Conference Coverage
More TOPCAT flaws back spironolactone’s HFpEF efficacy
Key clinical point: A post hoc analysis of spironolactone use among TOPCAT participants further fueled the idea that spironolactone provides real...
Conference Coverage
Elevated HDL levels predict reduced lung function
Key clinical point: In an evaluation of greater than 30,000 patients in six study cohorts, higher high-density lipoprotein cholesterol (HDL-C) was...
News
Study suggests link between commonly used antihypertensive drug and skin cancer
Despite its widespread use as a guideline-recommended, first-line agent for the treatment of hypertension, hydrochlorothiazide (HCTZ) may...
Conference Coverage
Novel GLP-1 receptor agonist shows reduction in cardiovascular risk
Key clinical point: The glucagonlike peptide 1 receptor agonist semaglutide may reduce the risk of cardiovascular events in patients with type 2...